IL17A and chronic obstructive pulmonary disease: TNF-α promotes neutrophilic inflammation and alveolar destruction, IL-6 contributes to systemic inflammation and COPD-associated comorbidities, and IL-17 drives neutrophilic recruitment and airway remodeling, contributing to chronic inflammation and steroid resistance (12, 19).